Funder
American Cancer Society
Florida Biomedical Research Program
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Ferla R, Calo V, Cascio S, et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007;18(Suppl_6):93–8.
2. Nilsson MP, Hartman L, Kristoffersson U, et al. High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer. Breast Cancer Res Treat. 2014;147:571–8.
3. Graeser MK, Engel C, Rhiem K, et al. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. J Clin Oncol. 2009;27:5887–92.
4. Metcalfe KA, Lynch HT, Ghadirian P, et al. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. Gynecol Oncol. 2005;96:222–6.
5. National Comprehensive Cancer Network (NCCN). Breast cancer risk reduction (version 2.2018). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) 2018.
https://www.nccn.org/professionals/physician_gls/pdf/breast_risk.pdf
. Retrieved 12 Nov 2018.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献